Q1 2011

Filed Sep 9, 2010 · 10-Q · 40 days after period end · 0001193125-10-207385

Q1 2011 · 10-Q

Revenue—

Net Income

$3.00M

no prior Q1 2010 on file

EPS Diluted

-$0.13

no prior Q1 2010 on file

Gross Profit$5,110—

Operating Income$3,023,201—

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jul 31, 2010 · filed Sep 9, 2010 · 40 d after period end

Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR